Uncategorized
Single low-dose bevacizumab injection promising for treating type 1 ROP
VANCOUVER, British Columbia — A single low-dose injection of bevacizumab as primary intervention yielded a “good success rate” in treating type 1 retinopathy of prematurity, according to a study presented here.However, “a second bevacizumab injection has not been successful in our experience,” Terry S. Kang, MD, told colleagues at the American Association for Pediatric Ophthalmology and Strabismus meeting.